Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Pfizer (PFE) Q4 Earnings Top, 2023 View Disappoints, Stock Down
03:49pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
Pfizer (PFE) beats estimates for Q4 earnings and sales. Its 2023 financial outlook falls short of expectations. Stock down in pre-market trading.
Qiagen (QGEN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
03:01pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Down 14.5%, Is Pfizer Stock a Screaming Buy?
09:00pm, Monday, 30'th Jan 2023 The Motley Fool
Pfizer's declining COVID-19 franchise and upcoming patent expirations have weighed heavily on its stock.
3 Top Dividend Stocks to Maximize Your Retirement Income
02:10pm, Monday, 30'th Jan 2023 Zacks Investment Research
The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate i
Investing in Cancer Stocks
10:43am, Monday, 30'th Jan 2023
Learn about some of the leading cancer stocks in the U.S stock market this year.
How Will Bristol Myers Squibb Stock Trend Post Q4 Results?
07:00am, Monday, 30'th Jan 2023
A decline in Revlimid sales will likely more than offset sales growth for Eliquis, Opdivo, and Reblozyl.
2 Top Dividend Stocks to Buy in 2023 and Hold Forever
01:53pm, Sunday, 29'th Jan 2023 The Motley Fool
These companies are established leaders in their respective fields.
2 Top Dividend Stocks to Buy in 2023 and Hold Forever
08:53am, Sunday, 29'th Jan 2023
These companies are established leaders in their respective fields.
Dividend Champion, Contender, And Challenger Highlights: Week Of January 29
06:36am, Sunday, 29'th Jan 2023 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.
Dividend Champion, Contender, And Challenger Highlights: Week Of January 29
01:36am, Sunday, 29'th Jan 2023
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
10:45pm, Friday, 27'th Jan 2023 Zacks Investment Research
Bristol Myers Squibb (BMY) closed at $72.45 in the latest trading session, marking a -0.74% move from the prior day.
Bristol-Myers (BMY) to Report Q4 Earnings: What's in Store?
04:28pm, Friday, 27'th Jan 2023 Zacks Investment Research
Investors are likely to focus on the demand for Eliquis and Opdivo, along with an incremental contribution from newer drugs, when Bristol-Myers (BMY) reports Q4 results.
Bristol-Myers (BMY) to Report Q4 Earnings: What's in Store?
12:47pm, Friday, 27'th Jan 2023
Investors are likely to focus on the demand for Eliquis and Opdivo, along with an incremental contribution from newer drugs, when Bristol-Myers (BMY) reports Q4 results.
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
11:50am, Friday, 27'th Jan 2023 The Motley Fool
These companies have the therapies to boost revenue for a decade.
Earnings Preview: Bristol Myers Squibb (BMY) Q4 Earnings Expected to Decline
03:01pm, Thursday, 26'th Jan 2023 Zacks Investment Research
Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
